| 000 | 01769 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514031912.0 | ||
| 264 | 0 | _c20020528 | |
| 008 | 200205s 0 0 eng d | ||
| 022 | _a0732-183X | ||
| 024 | 7 |
_a10.1200/JCO.2002.08.023 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRubnitz, Jeffrey E | |
| 245 | 0 | 0 |
_aFavorable impact of the t(9;11) in childhood acute myeloid leukemia. _h[electronic resource] |
| 260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cMay 2002 |
||
| 300 |
_a2302-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aChromosome Aberrations |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Rearrangement |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aLeukemia, Myeloid _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aRaimondi, Susana C | |
| 700 | 1 | _aTong, Xin | |
| 700 | 1 | _aSrivastava, Deo Kumar | |
| 700 | 1 | _aRazzouk, Bassem I | |
| 700 | 1 | _aShurtleff, Sheila A | |
| 700 | 1 | _aDowning, James R | |
| 700 | 1 | _aPui, Ching-Hon | |
| 700 | 1 | _aRibeiro, Raul C | |
| 700 | 1 | _aBehm, Frederick G | |
| 773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 20 _gno. 9 _gp. 2302-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.2002.08.023 _zAvailable from publisher's website |
| 999 |
_c11881398 _d11881398 |
||